JUL 17, 2018 01:17 PM PDT

Hunger Hormones for Addiction Treatment?

WRITTEN BY: Nouran Amin

Hunger hormones, or gut hormones, work to signal the body's state of hunger and fullness. These hormones could potentially serve as a key new treatment for drug and alcohol addiction.

After gut hormones have received attention from scientists seeking to understand ingestive behavior and obesity, researchers have discovered a relation between these particular hormones and addiction.

"Hormones from the gut act in the brain to modulate dopamine signaling, which controls decisions to seek out rewards," explained Dr. Mitchell Roitman from the University of Illinois-Chicago. This explains how food and water become more or less rewarding based on an individuals state of hunger, fullness, or thirst.

Addiction, for example, from cocaine and alcohol act on those same dopamine circuits in the brain, gut hormones could potentially turn their rewarding effects up or down in the same fashion.

Ghrelin, a hunger hormone released by the stomach, can exert its effects on the reward value of alcohol much like it increases the reward value of food, according to results shared by Dr. Lorenzo Leggio, leader of a joint team from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA). Other gut hormones like GLP-1 and amylin, which are released during the process of ingestion, signal the brain when they had enough to eat.

The NIAAA/NIDA research team has shown that ghrelin promotes the alcohol-seeking behavior in individuals with alcohol use disorder. More recently, the research team studied rats that are genetically insensitive to ghrelin, an approach that further encourages the role of the ghrelin system in alcohol seeking.

"These results provide a strong rationale for clinical trials of GLP-1 analogs for people seeking addiction treatment," says Dr. Heath Schmidt of the University of Pennsylvania's Perelman Medical School. "Medications affecting GLP-1 and amylin are already FDA approved for Type II diabetes and obesity. These drugs could be re-purposed for treating drug craving and relapse."

Substance abuse disorders are currently one of the most prevalent and expensive chronic health problems. According to government statistics, in the United States, over 21 million adults need treatment for alcohol or illicit drug abuse. Behavioral therapy is the standard treatment approach, however, persistent cravings lead to an increase in relapse rates. Presently, only a few medications are approved to help manage cravings, but these medications do not hold high efficacy for all people.

Data from animal experiments and preliminary trials in humans continues to support the gut hormone system as the needed target for novel treatments.

Source: Society for the Study of Ingestive Behavior

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 27, 2018
Infographics
JUN 27, 2018
The Role of Biomarkers In Modern Medicine
A biomarker (short for biological marker) is a measurable indicator of some biological state or condition. The biomarker can be measured objectively and consistently. Biomarkers play signific...
JUL 17, 2018
Drug Discovery
JUL 17, 2018
Possible Therapeutic Drugs for Inherited Form of ALS
Roughly 20,000 people in the United States are diagnosed with Lou Gehrig’s Disease, better known as amyotrophic lateral sclerosis (ALS). ALS is a fat...
JUL 19, 2018
Cell & Molecular Biology
JUL 19, 2018
Stopping Structural Changes in Collagen may Prevent Lung Fibrosis
Lung fibrosis is a serious condition that thickens tissues in the lungs and makes it hard to breathe....
SEP 08, 2018
Drug Discovery
SEP 08, 2018
Protein Associated With ALS Inspires Drug Treatments
Neurodegenerative diseases, such as degenerative ataxia or amyotrophic lateral sclerosis (ALS), will progressively cause an affected individual to develop ...
SEP 11, 2018
Drug Discovery
SEP 11, 2018
Potential Non-Antibiotic Drug For Tuberculosis
After 10 years of research, scientists at the University of Manchester have created the first non-antibiotic drug that can successfully treat tuberculosis ...
OCT 09, 2018
Drug Discovery
OCT 09, 2018
Weight Loss Drug Reduces Incidence of Diabetes
A clinical trial weight loss drug, by the name of Lorcaserin—manufactured by Eisai Inc., was found to reduce the risk of diabetes by 19 percent in pa...
Loading Comments...